Funded from a grant from the Novo Nordisk Foundation, the goal of AIM-Bio is to drive innovation in research and education in manufacturing biopharmaceuticals based on the complementary experience and expertise at NC State and DTU.
The vision is that within 5 years:
- DTU will have research and educational programs in biopharmaceutical manufacturing
- NC State will have research and educational programs in the areas of cell engineering and process modeling and control
Learn about the complementary expertise that each university contributes to AIM-Bio below:
- Both DTU Bioengineering and DTU Chemical Engineering are known for their efforts within research and education in industrial biotechnology.
- The departments have particular strengths focused on the production of industrial products in the following areas:
- Cell factory engineering
- Metabolic engineering
- Process modeling
- Control and separation methods
- DTU will benefit from the NC State expertise and knowledge in biopharmaceutical processing and downstream purification and will harmonize biopharmaceutical manufacturing training in Denmark with the BTEC courses at NC State.
NC State Expertise
- NC State BTEC, the Department of Chemical and Biomolecular Engineering and the Department of Biomedical Engineering have a very strong focus on biopharmaceutical manufacturing engineering and the strengths include:
- Downstream processing (including recovery and purification)
- Novel materials and sensors
- GMP Manufacturing concepts
- NC State BTEC provides process research and development support and lifelong training to a variety of biopharmaceutical companies. AIM-Bio will help harmonize biomanufacturing training between the US and Denmark.
- NC State will benefit from the DTU expertise in industrial biotechnology to help drive growth in biomanufacturing research with emphasis on the following areas:
- Cell engineering of mammalian and yeasts hosts
- High throughput operations
- Process modeling and control
- Product recovery